Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

OTC Pain Management - US - June 2017

"A majority of consumers turn to some form of OTC (over-the-counter) pain management product to treat pain, with internal analgesics remaining the dominate choice for pain relief, though external analgesics continue to experience faster growth. Looking forward, consumers’ need for pain treatments is not expected to change, and a preference for familiar brands will remain; however, interest is growing for naturally-positioned remedies."
- Marissa Gilbert, Senior Health and Wellness Analyst

This Report discusses the following key issues:

  • Consumers who stock up are less satisfied with their pain reliever
  • Dependency concerns and war on opioids could impact analgesic sales
  • The benefits of feminine pain relievers less apparent to key consumer group

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Overview

    • What you need to know
      • Definition
      • Executive Summary

        • The issues
          • Consumers who stock up are less satisfied with their pain reliever
            • Figure 1: Keep OTC on hand and satisfaction with current pain reliever, by pain self-assessment, April 2016
          • Dependency concerns and war on opioids could impact analgesic sales
            • Figure 2: Dependency concern, April 2017
          • The benefits of feminine pain relievers less apparent to key consumer group
            • Figure 3: Feminine pain relievers work the same as any oral pain reliever, by age, April 2017
          • The opportunities
            • Those with unbearable, constant, long-term pain still seeking relief
              • Figure 4: Willingness to try new pain relievers, try anything, and rely on daily pain reliever, by pain self-assessments, April 2017
            • Newer pain relieving formats have limited use, yet significant potential
              • Figure 5: regular use and interest in using external patch/wrap and TENS device, April 2017
            • Free-from claims can boost natural perceptions
              • Figure 6: Share of pain reliever product launches, by claim, 2012-16
            • What it means
            • The Market – What You Need to Know

              • Sales of OTC remedies remain steady, a result of pervasive pain
                • External analgesics growing, while internal accounts for vital quantity
                  • OTC TENS market the new breakout in pain management
                    • Age dynamics and the war on opioids impact product sales
                    • Market Size and Forecast

                      • Pain and sales of OTC remedies are constant
                        • Figure 7: Total US sales and fan chart forecast of OTC analgesics and pain management devices, at current prices, 2012-22
                        • Figure 8: Total US retail sales and forecast of OTC analgesics and pain management devices, at current prices, 2012-22
                    • Market Breakdown

                      • Sales of pain relieving products continue in stride
                        • Figure 9: Total US retail sales and forecast of OTC analgesics and pain management devices, by segment, at current prices, 2012-22
                        • Figure 10: Total US retail sales and forecast of OTC analgesics and pain management devices, by segment, at current prices, 2015 and 2017
                    • Market Perspective

                      • OTC TENS market expected to grow; more devices hit the market
                        • Figure 11: Total US retail sales of OTC TENS devices, at current prices, 2014-16
                        • Figure 12: MULO sales of electrotherapy devices, by leading companies and brands, rolling 52 weeks 2016 and 2017
                    • Market Factors

                      • Age impacts choice in pain management
                        • Figure 13: US population aged 18 or older, by age, 2011-21
                      • The war on opioids: the push to reduce abuse
                      • Key Players – What You Need to Know

                        • J&J is the leader in pain management sales
                          • External analgesics segment growth outpaces internal remedies
                            • Minimal innovation and absence of a defined need stalls sales
                              • Free-from, improved package functionality, and product blurring
                              • Company and Brand Sales of OTC Pain Relievers

                                • Trust is reclaimed; J&J is back on top while Bayer and Pfizer drop
                                  • Figure 14: MULO sales of OTC pain medication and devices, by leading companies, rolling 52 weeks 2016 and 2017
                              • What’s Working?

                                • External analgesics’ sales boom due to a flood of Lidocaine
                                  • Figure 15: MULO sales of external analgesics, by leading brands, rolling 52 weeks 2016 and 2017
                                • J&J keeps gaining market share
                                  • Figure 16: MULO sales of internal analgesics, by leading companies and brands, rolling 52 weeks 2016 and 2017
                                • Retail presence a must for new introductions to gain widespread use
                                • What’s Struggling?

                                  • Minimal innovation stalls muscle support device and ice/heat pack sales
                                    • Figure 17: Total MULO sales of muscle/body support devices and ice/heat packs, rolling 52 weeks 2016 and 2017
                                  • “Pink” pain relievers are not attaining acceptance
                                    • Figure 18: MULO sales of feminine pain relievers, by leading brands, rolling 52 weeks 2016 and 2017
                                • What’s Next?

                                  • Fragrance-free and free-from ingredient claims on the rise
                                    • Figure 19: Share of pain reliever product launches, by claim, 2012-16
                                  • Reducing the pain of opening the pill bottle
                                    • New product launch blurs product lines
                                    • The Consumer – What You Need to Know

                                      • Most adults experience pain and in multiple places of the body
                                        • Internal analgesics are pervasive, external have more limited users
                                          • Retail stores are the go-to for pain relievers
                                            • For most people pain is occasional and tolerable
                                              • People focus on overall wellbeing and new products for relief
                                                • Many consumers keep a pain reliever on hand
                                                • Location of Pain

                                                  • Most adults experience pain; headache or back pain are leading types
                                                    • Figure 20: Location of pain repertoire, April 2017
                                                    • Figure 21: Location of pain, April 2017
                                                  • Number and types of pain experienced vary some by age
                                                    • Figure 22: Location of pain repertoire, by age, April 2017
                                                    • Figure 23: Location of pain, by age, April 2017
                                                  • Headaches and migraines impact women most
                                                    • Figure 24: Headache and migraine pain, by gender, April 2017
                                                  • White and Hispanic adults experience more pains
                                                    • Figure 25: Location of pain repertoire, by race and Hispanic origin, April 2017
                                                • Pain Reliever Usage

                                                  • Internal OTC pain relievers are the common go-to for relief
                                                    • Figure 26: Pain reliever use, April 2017
                                                  • External pain relievers have more limited regular users
                                                    • Figure 27: Profile of regular external OTC medicated rub/ointment pain reliever users, April 2017
                                                    • Figure 28: Profile of regular external OTC medicated patch/wrap pain reliever users, April 2017
                                                  • Newer pain relieving formats have limited use, yet significant potential
                                                    • Figure 29: Regular use and interest in using external patch/wrap and TENS device, April 2017
                                                  • Regular pain reliever use increases with additional pain experienced
                                                    • Figure 30: Regularly use for pain relief, by repertoire of source of pain, April 2017
                                                • Purchase Location

                                                  • Retail stores are the go-to for pain relievers
                                                    • Figure 31: Pain reliever purchase location, April 2017
                                                  • Young adults are shopping drug stores most for relief
                                                    • Figure 32: Pain reliever purchase location, by age, April 2017
                                                  • TENS devices have an online presence
                                                    • Figure 33: TENS device purchase location, April 2017
                                                • Pain Self-assessment

                                                  • For the most part pain occurs on occasion and is tolerable
                                                    • Figure 34: Pain self-assessment, April 2017
                                                  • Most people describe pain as somewhere in the middle
                                                    • Figure 35: Unbearable or tolerable pain self-assessment, by types of pain, April 2017
                                                    • Figure 36: Constant or occasional pain self-assessment, by types of pain, April 2017
                                                  • The more types the less tolerable the pain
                                                    • Figure 37: Unbearable or tolerable pain self-assessment, by repertoire of source of pain, April 2017
                                                  • Unbearable pain is more constant; tolerable pain is occasional
                                                    • Figure 38: Unbearable or tolerable pain self-assessment, by occasional or constant pain self-assessment, April 2017
                                                • General Attitudes and Behaviors

                                                  • People will seek out relief for the benefit of their health
                                                    • Figure 39: General attitudes and behaviors, April 2017
                                                  • Natural and non-medicinal options could ease dependency concerns
                                                      • Figure 40: General attitudes and behaviors, by gender and age, April 2017
                                                    • Those with unbearable, constant, long-term pain still seeking relief
                                                      • Figure 41: General attitudes and behaviors, by pain self-assessments, April 2017
                                                    • The type of pain people experience dictates pain reliever use
                                                      • Figure 42: Location of pain by general attitudes and behaviors, April 2017
                                                  • Attitudes toward OTC Medications

                                                    • Preparedness is the first defense in managing pain
                                                      • Figure 43: Attitudes toward OTC medications, April 2017
                                                    • Those with enduring pain keep something on hand, but are less satisfied
                                                      • Figure 44: Pain self-assessment, by Attitudes toward OTC medications, April 2016
                                                    • Older adults are habitual; young adults seek out value
                                                      • Figure 45: Attitudes toward OTC medications, by gender and age, April 2017
                                                    • Women using feminine pain relievers agree less with the need
                                                      • Figure 46: Feminine pain relievers work the same as any oral pain reliever, by age, April 2017
                                                  • Appendix – Data Sources and Abbreviations

                                                    • Data sources
                                                      • Sales data
                                                        • Fan chart forecast
                                                          • Consumer survey data
                                                            • Abbreviations and terms
                                                              • Abbreviations
                                                              • Appendix – The Market

                                                                  • Figure 47: Total US retail sales and forecast of OTC analgesics and pain management devices, at inflation-adjusted prices, 2012-22
                                                                  • Figure 48: Total US retail sales and forecast of OTC analgesics and pain management devices, by segment, at current prices, 2012-22
                                                                  • Figure 49: Total US retail sales of OTC analgesics and pain management devices, by channel, at current prices, 2012-17
                                                                  • Figure 50: MULO sales of electrotherapy devices, by leading companies and brands, rolling 52 weeks 2016 and 2017
                                                              • Appendix – Key Players

                                                                  • Figure 51: MULO sales of external analgesics, by leading companies and brands, rolling 52 weeks 2016 and 2017
                                                                  • Figure 52: MULO sales of muscle/body support devices, by leading companies and brands, rolling 52 weeks 2016 and 2017
                                                                  • Figure 53: MULO sales of ice/heat packs, by leading companies, rolling 52 weeks 2016 and 2017
                                                              • Appendix – The Consumer

                                                                  • Figure 54: Profile of regular heat/ice pack pain reliever users, April 2017
                                                                  • Figure 55: Profile of regular muscle/body support pain reliever users, April 2017

                                                              Companies Covered

                                                              To learn more about the companies covered in this report please contact us.

                                                              OTC Pain Management - US - June 2017

                                                              US $3,995.00 (Excl.Tax)